Eli Lilly and Company
Sector
Location
Market Cap
USD 636.32 B
Share Price
USD 709.82
Avg Daily Volume
4,383,438
Change (1 day)
Change (1 year)
Change (YTD)
Neurocrine Biosciences, Inc.
USD 135.28
NBIX
Corcept Therapeutics Incorporated
USD 70.98
CORT
Jazz Pharmaceuticals plc
USD 120.53
JAZZ
H. Lundbeck A/S
USD 6.10
HLUN-B.CO
Axsome Therapeutics, Inc.
USD 117.14
AXSM
SK Biopharmaceuticals Co., Ltd.
USD 70.56
326030.KS
Alkermes plc
USD 29.06
ALKS
ACADIA Pharmaceuticals Inc.
USD 24.79
ACAD
Indivior PLC
USD 24.05
INDV
Supernus Pharmaceuticals, Inc.
USD 43.32
SUPN
Biohaven Ltd.
USD 14.68
BHVN
AbbVie Inc.
USD 209.50
ABBV
Roche Holding AG
USD 339.30
RO.SW
Novartis AG
USD 127.19
NOVN.SW
Novo Nordisk A/S
USD 55.23
NOVO-B.CO
Date | Accounts Payable | Short-Term Debt | Long-Term Debt | Total Liabilities |
---|
Neurocrine Biosciences, Inc.
USD 135.28
NBIX
Corcept Therapeutics Incorporated
USD 70.98
CORT
Jazz Pharmaceuticals plc
USD 120.53
JAZZ
H. Lundbeck A/S
USD 6.10
HLUN-B.CO
Axsome Therapeutics, Inc.
USD 117.14
AXSM
SK Biopharmaceuticals Co., Ltd.
USD 70.56
326030.KS
Alkermes plc
USD 29.06
ALKS
ACADIA Pharmaceuticals Inc.
USD 24.79
ACAD
Indivior PLC
USD 24.05
INDV
Supernus Pharmaceuticals, Inc.
USD 43.32
SUPN
Biohaven Ltd.
USD 14.68
BHVN
AbbVie Inc.
USD 209.50
ABBV
Roche Holding AG
USD 339.30
RO.SW
Novartis AG
USD 127.19
NOVN.SW
Novo Nordisk A/S
USD 55.23
NOVO-B.CO